Pain Management News and Articles

Conference Detail

View All Pain Management Conferences Post a Conference Calendar Map Conference Coverage

Pain Management Conference Details

15th World Congress on Pain CME

October 6-11, 2014
Buenos Aires, Argentina
The Congress will attract more than 6,000 pain specialists from all over the world who will converge on Buenos Aires and present the most up-to-date information on the field of pain, from laboratory science to clinical diagnosis, management, and prevention. The Buenos Aires Scientific Program Committee will organize a program to include plenary sessions, topical workshops, refresher courses, and poster sessions covering every aspect of acute and chronic pain from basic science to clinical practice

Venue: La Rural Convention Center
Conference Full List

Prepare for This Meeting

Read Article Summaries From Top Medical Journals

1 Neurostimulation for neck pain and headache Headache: The Journal of Head and Face Pain, February 18, 2014 Review Article

2 A critical evaluation of migraine trigger site deactivation surgery Headache: The Journal of Head and Face Pain, October 23, 2013

3 Noninvasive Pulsed Radio Frequency Energy in the Treatment of Occipital Neuralgia with Chronic, Debilitating Headache: A Report of Four Cases Pain Medicine, April 16, 2013

4 Concomitant persistent pain in classical trigeminal neuralgia - evidence for different subtypes Headache: The Journal of Head and Face Pain, May 30, 2014 Evidence Based Medicine

5 Neuromodulation for intractable headaches Current Pain and Headache Reports, February 12, 2014 Review Article

Related Quizzes From Smartest Doc

Question: Which division of the trigeminal nerve is NOT primarily involved with severe pain in patients with trigeminal neuralgia?

Question: Approximately what percent of patients with trigeminal neuralgia involving the 3rd branch are pain-free at 12 months following percutaneous retrogasserian glycerol rhizolysis?

Question: Compared to tapentadol extended-release (ER) 300mg plus pregabalin 300 mg in patients with severe chronic low back pain with a neuropathic component, tapentadol ER 500 mg is significantly associated with:

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
An error occurred getting the question data.

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More